Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2014; 20(38): 13987-13992
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13987
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13987
S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
Qing-Hua Ke, Shi-Qiong Zhou, Ji-Yuan Yang, Wei Du, Gai Liang, Yong Lei, Fei Luo, Department of Chemoradiotherapy, Oncology Hospital of Jingzhou, Jingzhou 434000, Hubei Province, China
Author contributions: All the authors contributed equally to this manuscript.
Correspondence to: Ji-Yuan Yang, Professor, Department of Chemoradiotherapy, Oncology Hospital of Jingzhou, No. 40 Jinglong Road, Shashi District, Jingzhou 434000, Hubei Province, China. yangjiyuancn@yeah.net
Telephone: +86-716-8257666 Fax: +86-716-8257666
Received: February 11, 2014
Revised: April 16, 2014
Accepted: June 26, 2014
Published online: October 14, 2014
Processing time: 246 Days and 16.4 Hours
Revised: April 16, 2014
Accepted: June 26, 2014
Published online: October 14, 2014
Processing time: 246 Days and 16.4 Hours
Core Tip
Core tip: The article describes a study of the combination of S-1 with gemcitabine S-1 followed by oral S-1 with concurrent radiotherapy and maintenance therapy with S-1 for locally advanced pancreatic cancer. It is considered a well-tolerated, promising and effective treatment for unresectable advanced pancreatic cancer.